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Objective: Our aim was to compare the outcome of esophageal resection
for carcinoma in elderly patients (aged over 70 and over 80 years) with
that of younger patients managed within a single specialist thoracic
surgery unit. Patients and methods: Between January 1987 and November
1997, 523 patients underwent esophagectomy for carcinoma in the
Nottingham City Hospital Thoracic Surgery Unit. The patients were
divided into 3 groups by age: group I, under 70 years (n = 337); group
II, 70 to 79 years (n = 150), and group III, 80 to 86 years (n = 36). These
groups were compared with regard to preoperative medical status, oper-
ability and resectability, complications, operative mortality, and long-
term survival. Results: Patients in groups II (6.0%) and III (2.8%) had
fewer preexisting respiratory problems than patients in group I
(12.5%), and the patients in group III had fewer preexisting cardiovas-
cular problems (16.7%) than patients in groups I (25.2%) and II
(32.7%). Although patients in group III were generally less likely to have
operable lesions (64.3%), no significant differences in resectability rate
were detected among the 3 groups (80.8%, 77.7%, and 80%). Elderly
patients (groups II and III) had a higher incidence of overall (34% and
36.1%), respiratory (24.7% and 19.4%), and cardiovascular (7.3% and
11.1%) complications than those aged under 70 years (24.6%, 16.3%,
and 2.1%, respectively). However, operative mortality (4.7%, 6.7%, and
5.6%) and 5-year survivals inclusive of operative mortality (25.1%,
21.2%, and 19.8%) were similar among the 3 groups. Conclusions:
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society whose elderly population is growing, it is not
surprising that the number of elderly patients referred
to thoracic surgeons for esophagectomy is rising. The
proportion of elderly patients (aged over 70 years) hav-
ing an esophagectomy for carcinoma in our unit has
steadily risen from 16.5% in 1987 to 43% in 1997 (c 2
test for trend, P = .01) (Fig 1).
Esophageal resection has generally been associated
with high morbidity and mortality rates. The increased
risk of surgical treatment in elderly patients has to be
balanced with the view that resectional surgery offers
the only real hope of cure in most circumstances.
Previous studies on the advisability of operation in
elderly patients have resulted in conflicting views.1-7 In
this report we compare the results of surgery in patients
in their eighth and ninth decades of life with those of
patients aged less than 70 years to assess the role of
esophageal resection in elderly patients.
Patients and methods
Between January 1987 and November 1997, 686 patients
with carcinoma of the esophagus or gastroesophageal junction
were evaluated with a view to performing esophagectomy.
Thirty-one patients (4.5%) were believed to be unsuitable for
surgery on medical grounds and the remaining 655 (95.5%)
had a surgical exploration. In 523 patients (79.8%) esophageal
resection was accomplished. These 523 patients were divided
into 3 groups by age: group I, under 70 years; group II, 70 to
79 years; and group III, 80 to 86 years. (Demographic details
and age distributions are shown in Table I and Fig 2). These
groups were compared with regard to their preoperative fit-
ness, operability and resectability rates, tumor characteristics
and pathologic features, type of operation, length of hospital
stay, prevalence of postoperative complications, operative
mortality, and 5-year survival.
Preoperative evaluation was by means of physical exami-
nation, hematologic and biochemical investigations, chest x-
ray radiography, barium meal, abdominal ultrasound, and
esophagogastroscopy. Bone scan was performed if indicated.
Major airways involvement by tumor was excluded where
appropriate by bronchoscopy.
Computed tomographic scan was not routinely performed
because experience in this unit showed it to be a poor means
of assessing both mediastinal tumor extent and lymph node
status.8 Our experience with endoscopic ultrasound, although
brief, was soon abandoned as, apparently, providing no bene-
fit. Its value is currently being reassessed in the light of expe-
rience of other units. Spirometry, capillary blood gas analy-
sis, and electrocardiography were routine. Exercise tests were
carried out in all patients above the age of 70 years, in those
with lung volumes of less than 60% of predicted value for age
and height, or in those with significant ischemic changes on
the electrocardiogram.
Patients were considered eligible for a surgical exploration
if they had no evidence of metastatic disease on screening
tests and appeared to have adequate cardiorespiratory
reserve. In general, patients more than 70 years old were very
unlikely to qualify for an operation if they had a forced expi-
ratory volume in 1 second of less than 50% of the predicted
value for weight and height, vital capacity of less than 50%
predicted, or if they were unable to complete stage I of the
Bruce protocol (in the absence of musculoskeletal disorder)
on exercise testing owing to symptoms or signs of myocardial
ischemia or desaturation on exercise.
All operations were performed by the same team of three
thoracic surgeons who used similar surgical techniques and
uniform perioperative management.
Extensive mediastinal dissection was routinely carried out
and included all periesophageal tissues with the subcarinal,
paratracheal and parahiatal lymph nodes, both parietal pleu-
rae overlying the esophagus, and the aortic adventitia. In the
abdomen the lymph nodes from the left gastric artery pedicle
were routinely excised, flush ligation of the left gastric pedi-
cle being achieved by application of a vascular stapler (TLV-
30 Auto Suture UK, Division of United States Surgical
Corporation, Norwalk, Conn).
After the operation, all patients were transferred to the
intensive care unit for a short period to allow elective removal
of the endotracheal tube before their return to the ward.
Postoperative analgesia was initially provided by means of
continuous infusion of a local anesthetic (bupivacaine) and an
opioid (fentanyl) mixture through an epidural catheter.
Parenteral or enteral nutrition was not used. Barium swallow
was carried out on the seventh postoperative day to check for
anastomotic integrity before the commencement of oral feeding.
Preoperative chemotherapy or radiotherapy was not given in
view of the conflicting evidence of its benefit.9
Operative mortality includes all in-hospital deaths plus any
death occurring after the patient was discharged from the hos-
pital within 30 days of the operation.
Follow-up. The unit policy is for life-long follow up. Patients
were seen in the outpatient clinics every 3 months for the first
year, every 6 months for the next 2 years, and yearly thereafter.
Survival time was calculated from the time of the operation
until death or until the end of the study period. Relevant
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may account for a low hospital mortality in elderly patients despite a
greater operative risk. The survival benefit is similar to that in the
younger age groups, enforcing the view that esophagectomy within spe-
cialist thoracic units can be safely offered (in appropriately selected
patients) with acceptable long-term survival in all age groups. (J Thorac
Cardiovasc Surg 1998;116:545-53)
information was obtained from the patients’ medical records,
the patients’ general practitioners, and the Thoracic Surgery
Audit Database.
Statistics. Survival distribution was calculated by means of
the product-limit method of Kaplan and Meier and includes
operative mortality and all causes of death. In univariate
analysis, survival curves were compared with log-rank test
and proportions with the c 2 test or Fisher’s exact test as
appropriate. Further comparisons between each pair of
groups were made only if the overall P value was less than
.05. A P value of less than .05 was used as guide to statistical
significance. Multivariate adjustment for preoperative med-
ical problems (risk factors) involved Cox proportional haz-
ards and logistic regression analysis. Nonparametric tests
were used to make between-group comparisons for the con-
tinuous variables length of tumor and length of hospital stay
because of the non-normality of their distributions. All statis-
tical analyses were done with the use of the statistical pack-
age SPSS PC (version 7.5) (SPSS Inc, Chicago, Ill).
Results
Fitness for operation, operability, and resectability.
Among those patients who were initially evaluated (n =
686), a significantly higher proportion of octogenarians
(19.6%) were considered to be medically unfit for an
operation than was the case in patients aged from 70 to
79 (4.9%) and under 70 years (2.3%), as shown in
Table II. As a result, the operability rate (defined as the
proportion of the patients who underwent a resection
among those who were initially evaluated with a view
to esophagectomy) was significantly lower in group III
(64.3%) than in groups I (78.9%) and II (73.9%) (P =
.03, c 2). The resectability rate, however (defined as the
proportion of the patients who underwent a resection
among those who underwent surgical exploration) was
similar (77.7%-80.8%) among all 3 groups.
Clinical features, tumor characteristics, operative
approach, and histologic type. Among those who had
a resection (n = 523), both septuagenarians and octo-
genarians had fewer preexisting respiratory problems
(eg, chronic obstructive airways disease, asthma, tuber-
culosis) than the patients aged less than 70 years.
Preexisting cardiovascular problems (eg, ischemic
heart disease, hypertension, myocardial infarction,
peripheral vascular disease, deep venous thrombosis)
were more prevalent in group II than in the other 2
groups (Table III). 
Tumor site and characteristics are shown in Table IV.
The surgical approaches and anastomotic techniques
used are shown in Table V. Twenty-eight transhiatal
resections were carried out during the first 5 years of
the study period. The procedure was later abandoned,
however, because it showed no advantage in terms of
morbidity and mortality and was thought to provide
inadequate mediastinal clearance.
Histologic examination of the resected specimens
showed that adenocarcinoma was about twice as com-
mon as squamous cell carcinoma in all 3 groups.
Barrett’s esophagus was present in 113 specimens with
adenocarcinoma and in 2 with histologically undifferen-
tiated tumors. A large proportion of the patients had
advanced tumors, that is, stage III (56.2%) (Table VI).
Morbidity, operative mortality, and hospital stay.
Overall postoperative complications were significantly
more prevalent in the elderly groups of patients (34%
and 36.1%) than in the patients aged less than 70 years
(24.6%), as shown in Table VII. Postoperative complica-
tions also tended to occur more often in those with pre-
existing respiratory or cardiovascular problems (c 2 test,
P = .04 and P = 0.06, respectively). After adjustment for
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Fig 1. Percentage of patients older than 70 years having esophagectomy.
Fig 2. Age distribution per decade of life.
preexisting disease, the odds ratios (95% confidence
interval) for postoperative complications were 1.6 (1.06,
2.49) and 1.9 (0.93, 4.02) for the over-70 and over-80
groups, respectively (Ptrend = .01).
Remarkably, the higher prevalence of postoperative
complications in the patients aged more than 70 or 80
years was not accompanied by a higher operative mor-
tality (Table VIII). Sixteen deaths occurred in group I
(4.7%), 10 in group II (6.7%), and 2 (5.6%) in group III.
Operative mortality was marginally increased in rela-
tion to preexisting respiratory problems (P = .15), but
not cardiovascular problems (P = .5), and remained
unrelated to age group even after adjustment for preex-
isting disease (Ptrend = .4).
Respiratory complications (pulmonary infection, res-
piratory failure, and adult respiratory distress syn-
drome) were the major causes of death in groups I and
II, with anastomotic leaks being an important cause of
death in the first 2 groups and the only apparent cause
of death in the patients aged over 80 years. Cardio-
vascular events (myocardial infarction, ventricular
tachyarrhythmias, pulmonary embolism, and stroke)
accounted for 5 deaths in groups I and II (Table VIII).
Median hospital stay was increased marginally with
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Table I. Patient demographic details
Group
I II III Total
No. of patients 337 150 36 523
Age (y)
Mean 59.4 (SD 8.1) 73.6 (SD 2.6) 81.5 (SD 1.7) 65.0 (SD 10.2)
Range 28-69 70-79 80-86 28-86
Sex
Female 105 (31.2%) 47 (31.3%) 17 (47.2%) 169 (32.3%)
Male 232 (68.8%) 103 (68.7%) 19 (52.8%) 354 (67.7%)
SD, Standard deviation.
Table II. Fitness for operation, operability, and resectability
Group
I II III Total c 2 Test (for trend)
Patients assessed for operation 427 203 56 686
Patients unfit for operation 10 (2.3%) 10 (4.9%)† 11 (19.6%)* 31 (4.5%) P < .0001
(P < .0001)
Patients explored surgically 417 (97.7%) 193 (95.1%) 45 (80.4%) 655 (95.5%)
Patients having a resection 337 150 36 523 
Resectability rate 80.8% 77.7% 80.0% 79.8% P = .67
(P = .53)
Operability rate 78.9% 73.9% 64.3%‡ 76.2% P = .03
(P = .01) 
*Group I versus III, P < .0001.
†Group II versus III, P = .001.
‡Group I versus III, P = .01.
Table III. Preoperative medical problems
Group
I II III Total c 2 Test (for trend)
Respiratory 42 (12.5%) 9 (6.0%)* 1 (2.8%) 52 (9.9%) P = .03
(P = .01)
Cardiovascular 85 (25.2%) 49 (32.7%) 6 (16.7%) 140 (26.8%) P = .08
(P = .80)
Diabetes mellitus 15 (4.5%) 7 (4.7%) 4 (11.1%) 26 (5.0%) P = .21
(P = .20)
*Group I versus II, P = .03.
age group (12, 13, and 13.5 days, respectively; Table
VIII).
Palliation of the dysphagia. Besides an attempt at
cure, palliation of dysphagia is also important. Good
palliation of dysphagia was achieved in 413 patients
(79.0%). In all, 112 patients had symptoms of dyspha-
gia after they were discharged from the hospital and
required 1 to 4 dilatations: 76 patients (22.6%) in group
I, 30 patients (20.0%) in group II, and 6 patients
(16.7%) in group III. In 37 of these patients, anasto-
motic tumor recurrence was documented 3 to 50
months after the operation.
The exact incidence of malignant anastomotic recur-
rence is rather difficult to assess, because often patients
die of distant metastases and generalized disease away
from the hospital. The same seems to be true for the
very important issue of postesophagectomy quality of
life, the evaluation of which requires specifically
designed and executed studies, which are clearly
beyond the scope of this report.
The Journal of Thoracic and
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Table IV. Tumor characteristics
Group
I II III Total
Upper third 8 (2.4%) 5 (3.3%) 1 (2.8%) 14 (2.7%)
Middle third 69 (20.5%) 33 (22.0%) 7 (19.4%) 109 (20.8%)
Lower third 170 (50.4%) 64 (42.7%) 23 (63.9%) 257 (49.1%)
GE junction 90 (26.7%) 48 (32.0%) 5 (13.9%) 143 (27.3%)
Length 
Median 5 cm 5 cm 4.5 cm 5 cm
Range 0.5-14 cm 1-13 cm 2.5-11 cm 0.5-14 cm 
GE, Gastroesophageal. c 2 Test for tumor site: P = .31. Kruskal-Wallis test for tumor length, P = .11. Jonckheere-Terpstra test (ordering), P = .04.
Table V. Operative approach and anastomotic technique
Group
I II III Total
Left thoracotomy 172 (51%) 83 (55.3%) 21 (58.3%) 276 (52.8%)
Left thoracolaparotomy 49 (14.5%) 16 (10.7%) 6 (16.7%) 71 (13.6%)
Ivor Lewis 92 (27.3%) 45 (30%) 9 (25%) 146 (27.9%)
Transhiatal 23 (6.8%) 5 (3.3%) 0 28 (5.4%)
McKeown 1 (0.3%) 1 (0.7%) 0 2 (0.4%)
Stapled anastomosis 253 (75.1%) 106 (70.7%) 28 (77.8%) 387 (74.0%)
Hand anastomosis 84 (24.9%) 44 (29.3%) 8 (22.2%) 136 (26%)
c
2 Test for operative approach, P = .50. c 2 Test for anastomotic technique, P = .51.
Table VI. Tumor pathology and stage (AJCC criteria)
Group
I II III Total
Adenocarcinoma 213 (63.2%) 101 (67.3%) 25 (69.4%) 339 (64.8%)
Squamous cell carcinoma 111 (32.9%) 45 (30.0%) 10 (27.8%) 166 (31.7%)
Undifferentiated and 13 (3.9%) 4 (2.7%) 1 (2.8%) 18 (3.4%)
small cell carcinomas
Barrett’s esophagus 70 (20.8%) 38 (25.3%) 7 (19.4%) 115 (22.0%)
Involved lymph nodes 217 (64.4%) 86 (57.3%) 19 (52.8%) 322 (61.6%)
Uninvolved lymph nodes 120 (35.6%) 64 (42.7%) 17 (47.2%) 201 (38.4%)
Stage I 18 (5.3%) 10 (6.7%) 2 (5.6%) 30 (5.7%)
Stage IIa 88 (26.1%) 43 (28.7%) 14 (38.9%) 145 (27.7%)
Stage IIb 35 (10.4%) 15 (10.0%) 4 (11.1%) 54 (10.3%)
Stage III 196 (58.2%) 82 (54.7%) 16 (44.4%) 294 (56.2%)
AJCC, American Joint Committee on Cancer.24 c 2 Test for histologic cell type, P = .85. c 2 Test for Barrett’s esophagus, P = .50. c 2 Test for lymph node status, P =
.18 ( c 2 test for trend, P = .07). c 2 Test for pTNM stage, P = .74. 
Survival. The overall 5-year survival including post-
operative mortality and all causes of death was 23.8%
(median 19 months, 95% CI 16.4-21.6 months). Five-
year survival was higher in group I (25.1%, median 19
months, CI 15.8-22.2) and group II (21.2%, median 20
months, CI 15.1-24.9) than in group III (19.8%, medi-
an 20 months, CI 11-29 months), but not significantly
so (Fig 3). Neither preexisting respiratory disease nor
preexisting cardiovascular disease was a significant
predictor of survival (log-rank test, P = .4 for both), and
differences in survival between age groups remained
nonsignificant after adjusting in multivariate analysis
for preexisting disease (Ptrend = .35).
The overall 5-year survival among the 457 patients
(87.4%) who were considered to have a curative (no
microscopic or macroscopic evidence of residual dis-
ease) R0 resection was 26.7% (median survival 21
months, 95% CI 16.6-25.5 months). There were no sig-
nificant differences among the 3 groups (group I:
28.3%, median 21 months, CI 15.3-26.7 months; group
II: 23.9%, median 23 months, CI 13.1-32.9; group III:
21.6%, median 21 months, CI 11.0-31.0 months) (Figs
4 and 5).
However, none of the remaining 66 patients who had
a noncurative (evident microscopic-macroscopic resid-
ual disease) R1-2 resection survived longer than 31
months (median 13 months, 95% CI 10.2-15.8
months), with all 3 groups having similarly poor sur-
vivals (group I: median 14 months, CI 10.8-17.2; group
II: median 12 months, CI 4.4-19.6; and group III: 8
months, CI 0.2-15.8 months) (Figs 4 and 5).
Discussion
There are no scientifically established criteria to
define the term elderly, which is being used arbitrarily
in assessing the outcome after operations in patients
more than 70 years old.1-5 The proportion of septuage-
narians in our series (35.6%) (Fig 2) is higher than the
29.8%,1 22%,4 and 16.5%5 previously reported by
other authors.
Inasmuch as the number of patients with carcinoma
of the esophagus or cardia being referred at advanced
age is rising, both the referring physician and the tho-
racic surgeon need to meet the challenge. A conserva-
tive approach, often adopted by many physicians and
surgeons in the treatment of elderly patients with
esophageal carcinoma, is based, first, on the fear of
increased operative mortality and, second, on the per-
ception that these patients have a potentially short life
span. However, as shown here and reported elsewhere,5
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Table VII. Postoperative complications
Group
I II III Total c 2 Test
Overall 83 (24.6%) 51 (34.0%) 13 (36.1%) 147 (28.1%) P = .057
Respiratory 55 (16.3%) 37 (24.7%) 7 (19.4%) 99 (18.9%) P = .094
Cardiovascular 7 (2.1%) 11 (7.3%)* 4 (11.1%)† 22 (4.2%) P = .003
Supraventricular tachycardias 56 (16.6%) 26 (17.3%) 6 (16.7%) 88 (16.8%) P = .98
Anastomotic leaks 19 (5.6%) 8 (5.3%) 2 (5.6%) 29 (5.5%) P = .99
Chylothorax 15 (4.4%) 5 (3.3%) 1 (2.8%) 21 (4.0%) P = .78
*Group I versus II, P = .005 ( c 2 test).
†Group I versus III, P = 0.03 (Fisher’s exact test).
Table VIII. Mortality, causes of death, and hospital stay
Group
I II III Total Probability
Respiratory 8 4 12
Anastomotic leaks 4 2 2 8
Cardiovascular 2 3 5
Other 2 (sepsis) 1 (aortic rupture) 3
Overall mortality 16 (4.7%) 10 (6.7%) 2 (5.6.%) 28 (5.4%) P = .51 
(c 2 test for trend)
Hospital stay (days)
Median 12 13 13.5 12 P = .04* 
(Kruskal-Wallis)
Range 8-90 8-120 10-57 8-120
*Jonckheere-Terpstra test for trend, P = .02.
high operative mortality is not necessarily the case.
Furthermore, the average life expectancy in the United
Kingdom is 74 years for men and 79 years for
women,10 with the average life expectancy for octoge-
narians for men and women being 5.9 and 7.5 years,
respectively.11 Although forms of treatment other than
surgery, such as chemotherapy, radiotherapy, intuba-
tion, and laser therapy, can be considered, they are
essentially palliative. We would agree with others12 that
the feasibility of esophageal resection in elderly
patients depends partly on the anticipated benefits. In
this respect, surgery seems to offer the only real hope
for cure and the best form of palliation with acceptable
long-term quality of life.13 We therefore favor early
surgical exploration of all eligible patients, being pre-
pared to attempt complete resection in patients with
locally advanced but resectable disease.
An improvement in the preoperative staging with
reduction of the nonresectability rate (20% in this
series) is of course highly desirable, and in this respect
refinements in endoscopic ultrasonography and the
development of thoracoscopic-laparoscopic staging
methods appear to be promising.14
The resection rate in our series was similar in all 3
groups, but the percentage of those who were refused
an operation on medical grounds rose with age. In octo-
genarians this was 19.6% (Table II). Despite this pre-
caution, the elderly patients had more postoperative
complications than their younger counterparts (Table
VII). The 34.0% postoperative complication rate in
group II is higher than the 24.7% reported by Jougon
and associates5 but compares favorably with postoper-
ative complication rates of over 50% reported for sep-
tuagenarians by other authors.2,4 The 36.1% complica-
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Fig 3. Actuarial survival for all patients and for patients in groups I, II, and III (P = .88). 
Fig 4. Actuarial survival for patients having a curative (R0) or noncurative (R1-2) resection (P < .0001).
tion rate in our octogenarians is similar to that reported
by Adam and colleagues.6
The operative mortality was, however, kept low in all
3 age groups. The 6.7% operative mortality in group II
is lower than the recently reported 7.8%5 and compares
favorably with operative mortality rates of 13% to 21%
reported earlier, also for septuagenarians.1-4,15 The
5.6% operative mortality in patients in group III com-
pares favorably with operative mortality rates of 10% to
13% reported for octogenarians from other centers.6,7
The similar survival in the 3 groups (Fig 3) stresses
the point that the disease itself and not the patient age
is the limiting factor for long-term survival after
esophageal resection for carcinoma.
The 21.2% 5-year survival in group II compares favor-
ably with 5-year survivals of 19% and 13.5% reported in
septuagenarians by other authors,1,5 and the 19.8% 5-
year survival in group III also compares favorably with a
17% survival reported by Adam and associates6 in their
series of 31 octogenarians. Although the survival figures
quoted here leave much to be desired, sadly the bulk of
the evidence currently available suggests that use of
neoadjuvant treatment confers no overall survival bene-
fit beyond that achieved so far by surgery alone.16-18
Thus it seems that routine use of such treatment with its
associated toxicity is currently not justified.9,19 The prac-
tice is unusual in the United Kingdom.
It has been suggested that the transhiatal approach for
esophagectomy is less invasive20 and its use would
have been associated with reduced postoperative mor-
bidity and mortality, but this has not been proven.21,22
Regarding elderly patients, Naunheim and associates2
have reported similar mortality and morbidity figures in
patients treated with a transhiatal or transthoracic
approach in their series of 38 septuagenarians.
Our experience also suggests that thoracotomy is as
safe in the septuagenarians and octogenarians as in the
younger age patients. Only 5 of 186 patients in this
series over 70 years old had a transhiatal resection and
none over 80 years (Table V). In addition, the low oper-
ative mortality observed in all 3 age groups (Table VIII)
shows that selected elderly patients can tolerate with
somewhat increased morbidity an extensive mediasti-
nal dissection as well as the younger patients.
Although the competent performance of the opera-
tion itself is very important,23 we do not believe that the
type of surgical approach used is an important factor
affecting the immediate postoperative outcome. We
would emphasize instead the need for effective analge-
sia, the provision of vigorous physiotherapy, and the
prompt treatment of pulmonary infection, arrhythmias,
and other complications as soon as they occur.
It would appear that the immediate postoperative out-
come after esophagectomy depends heavily on the
adoption of a coordinated multidisciplinary approach
and teamwork in all aspects of perioperative manage-
ment of the often debilitated elderly patients with
esophageal cancer. This is perhaps more efficiently
achieved within specialist units with experience in the
management of thoracic problems.
Conclusions
Despite careful patient selection, postoperative com-
plications tend to occur more frequently in elderly
patients. Early recognition and effective treatment of
such complications in a unit managing large numbers
of patients with esophageal cancer, with more than one
third of them being over 70 years of age, seems to
account for a low operative mortality and short hospi-
tal stay in both septuagenarians and octogenarians. By
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Fig 5. Actuarial survival for each group of patients having a curative (R0) or noncurative (R1-2) resection
(P = .0003).
applying a thoracotomy-based operative approach with
extensive mediastinal dissection, regardless of age, we
were able to observe 5-year survivals of 20% or more
in all age groups. These data support the view that
esophageal resection for carcinoma within specialist
thoracic units is feasible and wholly appropriate for all
reasonably fit patients, regardless of age.
We are indebted to Lynda Beggs, Thoracic Surgery Audit
Officer at Nottingham City Hospital, for assistance with the
collection of data and the manuscript. Thanks are also due to
Andrea Venn, MSc, Medical Statistician, Department of
Respiratory Medicine, University of Nottingham, for carry-
ing out the statistical analyses and interpretation of the data.
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